{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:53:17Z","timestamp":1791445997751,"version":"4.3.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1U01DK137097"],"award-info":[{"award-number":["1U01DK137097"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>To address the challenges posed by inconsistent detection of analog insulin in commercially available insulin immunoassays, resulting in potential discrepancies in clinical findings and misdiagnosis during the investigation of factitious hypoglycemia., we aimed to evaluate the ability of the Siemens Atellica automated immunoassay to detect insulin analogs compared with LC-MS\/MS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Five insulin analogs were analyzed at 10\u2009ng\/mL spiked into serum samples, with recombinant human insulin as positive controls. Insulin and C-peptide assays were performed using Siemens Atellica and LC-MS\/MS. Recovery rates were calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Siemens Atellica immunoassay demonstrated robust cross-reactivity (92\u2013121%) of insulin analogs. In contrast, glargine was detected by LC-MS\/MS but other analogs were not observed (&lt;10% recovery).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results indicate that the insulin assay conducted on the Siemens Atellica platform could be used to diagnose factitious hypoglycemia by detecting the specific insulin analogs involved. The findings from our studies indicate the suitability of this method for clinical laboratory use in cases where factitious hypoglycemia is under consideration as a potential diagnosis. Clinicians should take these results into account when interpreting insulin measurements, particularly in instances where insulin analog overdose is suspected.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12020-024-03970-6","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T23:49:41Z","timestamp":1721432981000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Insights into insulin analog cross-reactivity: a comparative study of Siemens Atellica and LC-MS\/MS"],"prefix":"10.1007","volume":"87","author":[{"given":"Jieli","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Hatten-Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K. Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"issue":"Suppl 1","key":"3970_CR1","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.2337\/dc23-S009","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"N.A. ElSayed et al. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023. Diab. Care 46(Suppl 1), S140\u2013S157 (2023).","journal-title":"Diab. Care"},{"issue":"7","key":"3970_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrendo.2017.39","volume":"13","author":"C Mathieu","year":"2017","unstructured":"C. Mathieu, P. Gillard, K. Benhalima. Insulin analogues in type 1 diabetes mellitus: getting better all the time. Nat. Rev. Endocrinol. 13(7), 385\u2013399 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"3970_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/dme.12159","volume":"30","author":"AG Jones","year":"2013","unstructured":"A.G. Jones, A.T. Hattersley. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet. Med 30(7), 803\u2013817 (2013).","journal-title":"Diabet. Med"},{"key":"3970_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jmsacl.2022.06.003","volume":"25","author":"N Foulon","year":"2022","unstructured":"N. Foulon et al. Multiplexed quantification of insulin and C-peptide by LC-MS\/MS without the use of antibodies. J. Mass Spectrom. Adv. Clin. Lab 25, 19\u201326 (2022).","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"},{"issue":"8","key":"3970_CR5","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4158\/EP.14.8.1006","volume":"14","author":"JM Neal","year":"2008","unstructured":"J.M. Neal, W. Han. Insulin immunoassays in the detection of insulin analogues in factitious hypoglycemia. Endocr. Pr. 14(8), 1006\u20131010 (2008).","journal-title":"Endocr. Pr."},{"issue":"7","key":"3970_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJMc0807678","volume":"360","author":"SL Kao","year":"2009","unstructured":"S.L. Kao et al. An unusual outbreak of hypoglycemia. N. Engl. J. Med. 360(7), 734\u2013736 (2009).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"3970_CR7","first-page":"e62591","volume":"16","author":"M Akbari","year":"2018","unstructured":"M. Akbari et al. Factitious hypoglycemia caused by a unique pattern of drug use: a case report. Int J. Endocrinol. Metab. 16(1), e62591 (2018).","journal-title":"Int J. Endocrinol. Metab."},{"issue":"3","key":"3970_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ando.2023.03.015","volume":"84","author":"T Galvez","year":"2023","unstructured":"T. Galvez et al. Factitious hypoglycemia in insulin-treated diabetic patients. Ann. Endocrinol. 84(3), 364\u2013366 (2023).","journal-title":"Ann. Endocrinol."},{"issue":"10","key":"3970_CR9","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.2337\/dci23-0036","volume":"46","author":"DB Sacks","year":"2023","unstructured":"D.B. Sacks et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diab. Care 46(10), e151\u2013e199 (2023).","journal-title":"Diab. Care"},{"issue":"4","key":"3970_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4274\/jcrpe.1492","volume":"6","author":"O Nalbantoglu Elmas","year":"2014","unstructured":"O. Nalbantoglu Elmas et al. Importance of insulin immunoassays in the diagnosis of factitious hypoglycemia. J. Clin. Res Pediatr. Endocrinol. 6(4), 258\u2013261 (2014).","journal-title":"J. Clin. Res Pediatr. Endocrinol."},{"issue":"2","key":"3970_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2337\/diab.45.2.242","volume":"45","author":"DC Robbins","year":"1996","unstructured":"D.C. Robbins et al. Report of the American Diabetes Association\u2019s Task Force on standardization of the insulin assay. Diabetes 45(2), 242\u2013256 (1996).","journal-title":"Diabetes"},{"issue":"4","key":"3970_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1373\/clinchem.2006.082214","volume":"53","author":"S Marcovina","year":"2007","unstructured":"S. Marcovina et al. Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin. Chem. 53(4), 711\u2013716 (2007).","journal-title":"Clin. Chem."},{"issue":"5","key":"3970_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1373\/clinchem.2008.118380","volume":"55","author":"WG Miller","year":"2009","unstructured":"W.G. Miller et al. Toward standardization of insulin immunoassays. Clin. Chem. 55(5), 1011\u20131018 (2009).","journal-title":"Clin. Chem."},{"issue":"18","key":"3970_CR14","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.clinbiochem.2015.07.017","volume":"48","author":"C Parfitt","year":"2015","unstructured":"C. Parfitt et al. Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues. Clin. Biochem. 48(18), 1354\u20131357 (2015).","journal-title":"Clin. Biochem."},{"issue":"Pt 3","key":"3970_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/0004563214551613","volume":"52","author":"A Dayaldasani","year":"2015","unstructured":"A. Dayaldasani et al. Cross-reactivity of insulin analogues with three insulin assays. Ann. Clin. Biochem. 52(Pt 3), 312\u2013318 (2015).","journal-title":"Ann. Clin. Biochem."},{"key":"3970_CR16","doi-asserted-by":"publisher","first-page":"117516","DOI":"10.1016\/j.cca.2023.117516","volume":"548","author":"A Violin","year":"2023","unstructured":"A. Violin et al. Insulin: Know what your immunoassay detects. Evaluation of two new immunoassays. Clin. Chim. Acta 548, 117516 (2023).","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"3970_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1464-5491.2009.02815.x","volume":"26","author":"I Krull","year":"2009","unstructured":"I. Krull et al. Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays. Diabet. Med 26(10), 1075\u20131076 (2009).","journal-title":"Diabet. Med"},{"issue":"11","key":"3970_CR18","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1021\/ac050066i","volume":"77","author":"M Thevis","year":"2005","unstructured":"M. Thevis et al. Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. Anal. Chem. 77(11), 3579\u20133585 (2005).","journal-title":"Anal. Chem."},{"key":"3970_CR19","doi-asserted-by":"publisher","unstructured":"M. Thevis, A. Thomas, W. Schanzer. Insulin. Handb Exp. Pharmacol. (195) 209\u2013226 https:\/\/doi.org\/10.1007\/978-3-540-79088-4_10 (2010).","DOI":"10.1007\/978-3-540-79088-4_10"},{"issue":"5","key":"3970_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/dta.35","volume":"1","author":"A Thomas","year":"2009","unstructured":"A. Thomas et al. Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution\/high-accuracy mass spectrometry. Drug Test. Anal. 1(5), 219\u2013227 (2009).","journal-title":"Drug Test. Anal."},{"issue":"7","key":"3970_CR21","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1373\/clinchem.2005.065995","volume":"52","author":"M Moriyama","year":"2006","unstructured":"M. Moriyama et al. Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay. Clin. Chem. 52(7), 1423\u20131426 (2006).","journal-title":"Clin. Chem."},{"issue":"1","key":"3970_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1373\/clinchem.2003.026625","volume":"50","author":"WE Owen","year":"2004","unstructured":"W.E. Owen, W.L. Roberts, Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays. Clin. Chem. 50(1), 257\u2013259 (2004).","journal-title":"Clin. Chem."},{"issue":"3","key":"3970_CR23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1590\/S0004-27302007000300022","volume":"51","author":"JG Vieira","year":"2007","unstructured":"J.G. Vieira et al. Cross-reactivity of new insulin analogs in insulin assays. Arq. Bras. Endocrinol. Metab. 51(3), 504\u2013505 (2007).","journal-title":"Arq. Bras. Endocrinol. Metab."},{"issue":"1","key":"3970_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1185\/030079902125001416","volume":"19","author":"GU Kuerzel","year":"2003","unstructured":"G.U. Kuerzel et al. Biotransformation of insulin glargine after subcutaneous injection in healthy subjects. Curr. Med Res Opin. 19(1), 34\u201340 (2003).","journal-title":"Curr. Med Res Opin."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03970-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03970-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03970-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T12:52:38Z","timestamp":1737031958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03970-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["3970"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03970-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}